Russian produced anti-covid drug ready for exports

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russian coronavirus drug Avifavir in June, significantly exceeding initially planned production levels of 60,000 courses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3giKJWz
via IFTTT